Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jun;96(3):535-40.
doi: 10.1111/j.1365-2249.1994.tb06062.x.

Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers

Affiliations

Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers

T D de Gruijl et al. Clin Exp Immunol. 1994 Jun.

Abstract

The detection of antigen-specific T cell responsiveness, particularly of resting memory lymphocytes, in cultures of peripheral blood mononuclear cells (PBMC) may be hampered by a less than optimal antigen presentation in vitro. Augmented sensitivity of the test system may be achieved by the addition of reagents with a beneficial effect on lymphocyte and antigen-presenting cell (APC) functions. In this study the effect of several biological response modifiers on antigen-specific T cell proliferation was determined, using nickel sulphate and tetanus toxoid as test antigens. IL-1 alpha (100 U/ml), interferon-gamma (IFN-gamma) (10 U/ml), and indomethacin (2 microM) were found to significantly enhance nickel-induced proliferation in PBMC cultures from nickel-hypersensitive donors (n = 6). Tetanus-induced proliferation (n = 5) was similarly enhanced, both by the above supplements and by the addition of polyethylene glycol (PEG) or a neuraminidase treatment of the PBMC before culture. The addition to PBMC cultures of a combination of IL-1 alpha (30 U/ml), IFN-gamma (10 U/ml), and indomethacin (2 microM) is recommended to specifically enhance antigen-induced lymphoproliferative signals.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1985 Dec;135(6):3929-32 - PubMed
    1. J Immunol. 1985 Aug;135(2):1172-9 - PubMed
    1. J Immunol. 1986 Jul 15;137(2):519-24 - PubMed
    1. J Immunol. 1986 Oct 15;137(8):2448-54 - PubMed
    1. Immunobiology. 1986 Oct;173(1):82-97 - PubMed